Oncology Committee On Brain Tumor Endpoints Planned For Summer – Pazdur

FDA's Oncologic Drugs Advisory Committee could meet as soon as summer or early fall to discuss appropriate clinical trial endpoints for primary brain tumors, Office of Oncology Drug Products Director Richard Pazdur said Jan. 27 in an interview with "The Pink Sheet.